Наши научные публикации
2016
2017
- Annual Report 2013/14 German Childhood Cancer Registry. www.kinderkrebsregister.de p.39. [Assessed 2016, Agust 9th]
- Simon T, Berthold F, Borkhardt A, et al. Treatment and outcomes of patients with relapsed, high-risk neuroblastoma: Results of German trials. Pediatr Blood Cancer. 2011;56(4):578-583.
- Pinto NR, Applebaum MA, Volchenboum SL, et al. Advances in risk xlassification and treatment strategies for neuroblastoma. J Clin Oncol. 2015;33:3008-17.
Journal of Cancer Therapy(scientific research publishing)
- Brugiиres, L., Le Deley, M.C., Rosolen, A., Williams, D., Horibe, K., Wrobel, G., Mann, G., Zsiros, J., Uyttebroeck, A., Marky, I., Lamant, L. and Reiter, A. (2009) Impact of the Methotrexate Administration Dose on the Need for Intrathecal Treatment in Children and Adolescents with Anaplastic Large-Cell Lymphoma: Results of a Randomized Trial of the EICNHL Group. Journal of Clinical Oncology, 27, 897-903. https://doi.org/10.1200/JCO.2008.18.1487
- Lowe, E.J., Sposto, R., Perkins, S.L., Gross, T.G., Finlay, J., Zwick, D., Abromowitch, M. and Children’s Group Study 5941 (2009) Intensive Chemotherapy for Systemic Anaplastic Large Cell Lymphoma of Children and Adolescents: Final Results of Children’s Cancer Group Study 5941. Pediatr Blood Cancer, 52, 335-339. https://doi.org/10.1002/pbc.21817
- Rosolen, A., Pillon, M., Garaventa, A., Burnelli, R., d’Amore, E.S., Giuliano, M., Comis, M., Cesaro, S., Tettoni, K., Moleti, M.L., Tamaro, P., Visintin, G. and Za- nesco, L. (2005) Anaplastic Large Cell Lymphoma Treated with a Leukemia-Like Therapy: Report of the Italian Association of Pediatric Hematology and Oncology (AIEOP) LNH-92 Protocol. Cancer, 104, 2133-2140. https://doi.org/10.1002/cncr.21438
- Ward E, DeSantis C, Robbins A, Kohler B, Jemal A (2014) Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 64:83–103
- Gobbi PG, Ferreri AJ, Ponzoni M, Levis A (2013) Hodgkin lymphoma. Crit Rev Oncol Hematol 85:216–237
- Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P (2005) International classi?cation of childhood cancer, third edition. Cancer 103:67–1457
- Bleyer A, Barr R, Hayes-Lattin B, et al. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer. 2008;8: 288-298.
- Gatta G, Zigon G, Capocaccia R, et al. Survival of European chil- dren and young adults with cancer diagnosed 1995-2002. Eur J Cancer. 2009;45:992-1005.
- Trama A, Botta L, Foschi R, et al. Survival of European adolescents and young adults diagnosed with cancer in 2000-07: population- based data from EUROCARE-5. Lancet Oncol. 2016;17:896-906.
Human Vaccines & Immunotherapeutics
- Okeanov AE, Moiseyev PI, Levin LF, et al. Okeanov AE, Moiseyev PI, Levin LF, et al. Статичтика онкологических заболеваний в Республике Беларусь (2005– 2014) [Statistics of oncological diseases in the Republic of Belarus (2005–2014)]. Minsk, Belarus: N.N. Alexandrov National Cancer Centre of Belarus; 2015. Russian. (2005– 2014) [Statistics of oncological diseases in the Republic of Belarus (2005–2014)]. Minsk, Belarus: N.N. Alexandrov National Cancer Centre of Belarus; 2015. Russian
- Armitage JO. Non-Hodgkin lymphomas (2nd ed). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010.
- Kwak LW, Campbell MJ, Czerwinski DK, Hart S, Miller RA, Levy R. Induction of immune responses in patients with B- cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N Engl J Med. 1992;327(17):1209- 1215; PMID: 1406793; http://dx.doi.org/10.1056/ NEJM199210223271705
Clinical and laboratory observations
- Rezaei N, Hedayat M, Aghamohammadi A, et al. Primary immunodeficiency diseases associated with increased suscept- ibility to viral infections and malignancies. J Allergy Clin Immunol. 2011;127:1329–1341.
- Rezaei N, Mahmoudi E, Aghamohammadi A, et al. X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma. Br J Haematol. 2011;152:13–30.
- Overwater E, Smulders Y, Van Der Burg M, et al. 17-year-old boy with XLP de novo mutation. Eur J Pediatr. 2014;173: 1695–1698.
Allergologia et immunopathologia
- Conley ME, Rohrer J, Minegishi Y. X-linked agammaglobulinemia. Clin Rev Allergy Immunol. 2000;19:183---204
- Martini H, Enright V, Perro M, Workman S, Birmelin J, Giorda E, et al. Importance of B cell co-stimulation in CD4+ T cell dif- ferentiation: X-linked agammaglobulinaemia, a human model. Clin Exp Immunol. 2011;164:381---7.
- Vetrie D, Vorechovskyґ I, Sideras P, Holland J, Davies A, Flinter F, et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature. 1993 e;361:226---33.
International Journal of Mycobacteriology
Effectiveness of a novel cellular therapy to treat multidrug-resistant tuberculosis
- Wang H, Liddell CA, Coates MM, et al. Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384: 957–79.
- Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: e359–86.
- Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008; 9: 730–56.
- Алейникова О.В., Потапнев М.П., Сыцкевич О.Н., Петрович С.В., Исмаил-заде Р.С., Стронгин Ю.С., и др. Достижения детской онкологии и гематологии в Республике Беларусь. Актуальные вопросы детской онкологии и гематологии: Материалы VIII междунар. симп. Минск. 2000; 3-8.
- Суконко О.Г., Антоненкова Нат. А. Организациям здравоохранения в Республике Беларусь. Онкологический журнал. 2011; 20: 42-45.
- Демидчик Ю.Е., Писаренко А.М., Фридман М.В., Барагина З.Н., Меньковская С.В., Папок В.Е. Неоперируемый рак щитовидной железыЖ эффективность диагностики и выживаемость. Онкологический журнал. 2008; 8: 9-21.
- Schrappe M. Detection and management of minimal residual disease in acute lymphoblastic leukemia. Hematology Am. Soc. Hematol. Duc. Program. 2014; 2014(1): 244-9.
- Gulley M.L., Shea T.C., Fedoriw Y. Genetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemia. J. Mol. Diagn. 2010; 12(1): 3-16.
- Paietta E. Minimal residual disease in acute myeloid leukemia: coming of age. Hematology Am. Soc. Hematol. Educ. Program. 2012; 2012; 2012: 35-42.
- The Biology and Clinical Uses of Blood Stem Cells/L.B. To [et al.] // Blood. - 1997. - N 89.-P. 2233-2258.
- Defining a therapeutic dose of peripheral blood stem cells / J. G. Bender [er al.] // J. Hematother. - 1992. -N 1(4).-P. 329-341.
- Valeri, C.R. Effects of the temperature? the duration of frozen storage, and the freezing container on in vitro measurements in human peripheral blood mononuclear cells / C.R.Valeri, L.E. Pivace // Transfusion. -1996.-N36(4). -P.303-308.
- Петрович С.В., Алейникова О.В. // Медико-биологичю аспекты аварии на Чернобыльской АЭС. - 2004 - №1ю - С.3-11.
- Суконко О.Г., Антоненкова Н.А. // Онкологич. журнал. - 2011. - №20.-С.42-45.
- Демидчик Ю.Е., Писаренко А.М., Фридман М.В. и др. // Онкологич. журнал. - 2008. - №8. - С.9-21.
Вести Национальной академии наук Беларуси
- Aleinikova O.V., Potapnev M.P.,Sytskevich O.N., Petrovich S. V., Ismail-Zadeh R.S., Strongin Yu. C. "Advances in child oncology and hematology in the Republic of Belarus",Actual'nye voprosy detskoi onkologii i gematologii: materialy VIII mezhdunarodnogo simpoziuma, 27-29 aprelya 2000 g., g.Minsk [Urgent Problems of Child Oncology and Hemaology: Materials VIII Intern. Symp., April 27-29, 2000, Minsk], BelTsNMI, Minsk, BY, 2000, pp.3-8.
- Sukonko O.G., Antonenkova N.A. "Organizational, methodological assistance provided by the state institution "Republican Scientfic-Practical Center of Oncology, Medical Radiology named after N.N. Alexandrov" healthecare organizations in the Republic of Belarus", Oncologicheskii zhurnal [Oncological Journal], 2011, no. 20, pp. 42-45.
- Demidchick Yu.E., Pisarenko A.M., Fridman M.V., Baragina Z. N., Mankovskaya S. V., Papok V.E. "Non-operable thyroid cancer: effectivaness of diagnosis and survival", Onkologicheskii zhurnal [Oncological Journal], 2008, no. 8, pp. 9-21.
- Алейникова О.В., Потапнев М.П., Сыцкевич О.Н., Петро- вич С.В., Исмаил-заде Р.С., Стронгин Ю.С. и др. Достижения дет- ской онкологии и гематологии в Республике Беларусь. Актуаль- ные вопросы детской онкологии и гематологии: Материалы VIII междунар. симп. Минск. 2000; 3-8.
- Суконко О.Г., Антоненкова Нат.А. Организационно-мето- дическая помощь, оказываемая государственным учреждением РНПЦ ОМР им. Н.Н. Александрова организациям здравоохранения в Республике Беларусь. Онкологический журнал. 2011; 20: 42-45.
- Демидчик Ю.Е., Писаренко А.М., Фридман М.В., Бараги- на З.Н., Маньковская С.В., Папок В.Е. Неоперируемый рак щито- видной железы: эффективность диагностики и выживаемость. Онкологический журнал. 2008; 8: 9-21.
- Алейникова О.В., Потапнев М.П., Сыцкевич О.Н., Петрович С.В., Исмаил-заде Р.С., сТРОГИН ю.с., и др. Достижения детской онкологии и гематологии в Республике Беларусь. Актуальные вопросы детской онкологии и гематологии. Материалы VIII междунар. симп. Минск. 2000; 3-8.
- Суконко О.Г., Антоненкова Нат. Н. Организационно-матодическая помощь, оказываемая государственным учреждением РНПЦ ОМР им. Н.Н. Александрова организациям здравоохранения в Республике Беларусь. Онкологический журнал. 2011; 20; 42-45 в Республике Беларусь. Онкологический журнал. 2011; 20; 42-45.
- Демидчик Ю.Е., Писаренко А.М., Фридман М.В., Барагина З.Н., Меньковская С.В., Папок В.Е. Неоперируемый рак щитовидной железы: Эффективность диагностики и выживаемость. Онкологический журнал. 2008; 8; 9-21.
- Louis DN. Ohgaki H, Wiestler OD, Cavenee WK. World Health Organization histological classification of tumours of the central nervous system. International Agency for Research on Cancer. 2007, Lyon.
- Louis DN. The next step in brain tumor classifiation: "Let us now praise famous men"... or molecules? Acta Neuropathol. 2012; 124:761-762.
- Louis DN, Perry A, Burger P, Elloison DW, Refenberger G, von Deimling A, Aldape K, Brat D, Collins VP, Eberhart C et al. International Society Of NEuropathology-Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol. 2014, 24:429-435.
- Aoki, K. Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene / K. Aoki, M. M. Taketo // J. of Cell Sci. – 2007. – Vol. 120. – P. 3327–3335.
- Fearnhead, N. S. The ABC of APC / N. S. Fearnhead, M. P. Britton, W. F. Bodmer // Human Mol. Genetics. – 2001. – Vol. 10. – P. 721–733.
- Барашкова, E. С. Преобладающие типы нуклеотидных мутаций в гене APC человека, кодирующем белок, препятствующий развитию колоректального рака [Электронный ресурс] / Е. С. Барашкова, Т. А. Хрусталева, В. В. Хрусталев // Молодежь в науке : материалы XII Междунар. науч. конф. молодых ученых, 1–4 дек. 2015 г. / Нац. акад. наук Беларуси, Совет молодых ученых. – Электрон. текстовые, граф. данные и приклад. программа. – 1 комп. опт. диск (CD-ROM). – Mинск, 2015. – С. 73–84.
О.В. Петина, А.А. Зборовская
РНПЦ детской онкологии, гематологии и иммунологии, г. Минск, Беларусь
- Блохина Е.Б. Роль генетического полиморфизма в онкологии // Качественная клиническая практика. - 2004 - 1. С. 2-5.
- Чупова Н.В., Самочатова Е.В., Руднева А.Е. и др. Генетический полиморфизм типурин - S - метилтрансферазы в челении детей с острым лимфобрастным лейкозом // Гематология и трансфузиология. - 2005. - Vol. 50(6). - C. 3-9.
- M. Kantar, B.Kosova, N. Cetingul, et al. Methylenetetrahydrofolatereductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma // Leuk Lymphoma. - 2009. - Vol. 50. - N 6. - P.912-917.
- La Quaglia MP, Kushner BH, Su W, Heller G, Kramer K, Abramson S, et al. The impact of gross total resection on local control and survival in high-risk neuroblastoma. J Pediatr Surg 2004;39:412-7.
- Adkins ES, Sawin R, Gerbing RB, London WB, Matthay KK, Haase GM. Efficacy of complete resection for high-risk neuroblastoma: a Children's Cancer Group study. J Pediatr Surg 2004;39:931-6.
- La Quaglia MP, Kushner BH, Heller G, Bonilla MA, Lindsley KL, Cheung NK. Stage 4 neuroblastoma diagnosed at more than 1 year of age: gross total resection and clinical outcome. J Pediatr Surg 1994;29;1162-5.
- Stein Н., Mason D., Gerdes J., et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lym phoid tissue: evidence that Reed- Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood. 1985; 66(4): 848— 58.
- Delsol G., Jaffe E. S., Falini S., et al. Anaplastic large cell lymphoma, ALK-positive. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Swerdlow S. H., Campo Ј., Harris N. L., et al., IARC Pres, Lyon, France, 4th edition. 2008; 312— 6.
- Brugiures L „ Le Deley М. C., Rosolen A., et al. Impact o f the methotrexate adm inistration dose on the need for intrathecal treatm ent in children and adolescents with anaplastic large-cell lymphoma: results o f a random ized trial of the EICNHL Group. J. Clin. Oncol. 2009; 27(6): 897— 903.
- Sureda A., Constans M., Iriondo A., et al. Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse // Ann Oncol.-2005.- Vol.16, N 5. - P. 625-633.
- Majhail N.S., Weisdorf D.J., Defor T.E., et al. Long-term results of autologous stem call tramsplanration for primary refractory of relapsed Hodgkin's lymphoma//Biol Blood Marrow Transplant.-2006.-Vol.12, N 10. - P. 1065-1072.
- Arai S. Fanale M., deVas S., er al. Defining a hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant // Leuk Lymphoma.-2013.-Vol.54, N 11.-P.2531-2533.
Анапластическая крупноклеточная лимфома у детей и подростов: 25 лет терапии
- Jacobsen E. Anaplastic large-cell lymphoma, T-/null-cell type // Oncologist. - 2008. - Vol. 11, N8. - P. 831-840.
- Liang X., Meech S.J., Odom L.F., et al. Assessment of t(2;5)(p23;q35) translocaqtion and variants in pediatric ALK+anaplactic large cell lymphoma // Am J Clin Pathol. - 2004. - Vol. 121, N4. - P. 496-506.
- Seidemann K., Tiemann M., Schrappe M., et al. Short-pulse B-non-Hodgkin Lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: A report of the Berlin-Frankfurt-Monster Group Trial NHL-BFM 90 // Blood. - 2001. - Vol.97, N12. - P.3699-3706.
- Masetti R., Rondelli R., Fagioli F. et al. Infants with acute myeloid leukemia treated according to the Associazione Italiana di Ematologia e Oncologia Pediatrica 2002/01 protocol have an outcome comparable to that of older children. Haematologica 2014;99(8):e127–9. doi: 10.3324/haema- tol.2014.106526.
- Gibson B.E., Webb D.K., Howman A.J. et al.; United Kingdom Childhood Leukae- mia Working Group and the Dutch Child- hood Oncology Group. Results of a random- ized trial in children with Acute Myeloid Leukaemia: medical research council AML12 trial. Br J Haematol 2011;155(3):366–76. doi: 10.1111/j.1365-2141.2011.08851.x.
- Rubnitz J.E., Inaba H., Dahl G. et al. Minimal residual disease-directed therapy for childhood acute myeloid leukemia: results of the AML02 multicentre trial. Lancet Oncol 2010;11(6):543–52. doi: 10.1016/S1470- 2045(10)70090-5.
Службе специализированной помощи детям с онкологическими и гематологическими заболеваниями 20 лет
- Saletta F., Seng M., Lau L. (2014) Advances in paediatric cancer treatment. Transl Pediatr., vol. 3, no 2, pp. 156-82.
- Gibson B., Webb D., De Graaf S., Harrison C., Wheatley K. (2011) Result of a randomized trial in children with acute myeloid leukaemia: Medical Research Council AML 12 trial. British Journal of Haematology, vol. 155, no 3, pp. 366-376.
- Rubnitz J., Inaba H., Dahl G., Ribeiro R., Bowman W., Taub J. (2010) Minimal residual diseasedirected therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial. Lancet Oncology, vol. no 6, pp. 543-552.
Восточная Европа
2017, том 3, № 3
- Bousfiha A.A., Jeddane L., Ailal F., Benhsaien I., Mahlaoui N., Casanova J.L. (2013) Primary immunodeficiency diseases worldwide: more common than general thought. J. Clin. Immunol., vol. 33, no 1, pp. 1-7.
- Luncov A.V., Skorohodkina O.V., Nurhametova D.F. (2015) Infekcionnyi sindrom u bolnyh spervichnymi immunodeficitamii vozmozhnosti ego korekcii (Infectious syndrome in patients with primary immunodeficiencies and possibilities of its correction), Prakticheskaja medicina, vol. 2, no 4, pp. 72-75.
- Gathmann B.,Grimbacher B., Beaute J., Dudoit Y., Mahlaoui N., Fischer A.(2009) The European internet-based patient and research database for primary immunodeficiencies: results 2006-2008.ClinExplmmunol,vol. 157 (Suppl 1), pp. 3-11.
Хронический миелоидный лейкоз у детей (обзор литературы)
- Ries LAG, Melbert D, Krapcho M. SEER Cancer Statistics review. Bethesda, MD: NCI, 2008.
- CML: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. European Society for Medical Oncology. 2010.
- Josu de la Fuente J, Baruchel A, Biondi A, Eveline de Bont, Dresse M, Suttorp M, et al. Managing children with chronic myeloid leukaemia (CML): recommenda- tions for the management of CML in children and young people up to the age of 18 years. Br J Haematol. 2014;167(1):33-47.
Хронический миелоидный лейкоз у детей (обзор литературы)
- Ries LAG, Melbert D, Krapcho M. SEER Cancer Statistics review. Bethesda, MD: NCI, 2008.
- CML: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. European Society for Medical Oncology. 2010.
- Josu de la Fuente J, Baruchel A, Biondi A, Eveline de Bont, Dresse M, Suttorp M, et al. Managing children with chronic myeloid leukaemia (CML): recommenda- tions for the management of CML in children and young people up to the age of 18 years. Br J Haematol. 2014;167(1):33-47.
Редкий случай острого лимфобластного лейкоза у ребенка с болезнью Виллебранда
- Zharikova L., RumyantsevaYu., KarachunskyA. (2015) Thromboses in children with acute lymphoblastic leukemia. Pediatric Haematology/oncology and immunopathology, vol. 14, no 3, pp.39-47.
- Siegel R., Ward E., Brawley O., Jemai A.(2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.CA Cancer J Clin., vol.61, no 4,pp. 212-219.
- Hunault-Berger M.(2008) Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase inadult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma.
Тромбозы у детей с острым лимфобрастным лейкозом
- Raetz EA, Salzer WL. (2010) Tolerability and efficacy of L-asparaginase therapy in pediatric patients with acute lymphoblastic Leukemia. J Pediatr Hematol Oncol, vol. 32, no 7, pp.554-563.
- Payne JH, Vora AJ.(2007) Thrombosis and acite lymphoblastic leukaemia.Br J Haematol, vol.138, no 4, pp.430-439.
- Athale UH, Siciliano SA, Crowther M. (2005) Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Faber Cancer Institute protocols: effect of age and risk stratification of disease.Br J Haematol, vol. 129, pp. 803-814.
Влияние аспарагиназы на свертывание крови у детей с острым лимфобластным лейкозом
- Astwood E., Vora A. (2011) Personal practice: How we the risk of bleeding and thrombosis in children and young adults acute lymphoblastic leukaemia.British Journal of Haematology, vol. 152, pp. 505-511.
- Mitchell L.G., Sutor A.H., Andrew M. (1995) Hemostasis in childhood acute lymphoblastic leukenia: coagulopathy induced by disease and tretment. Semin. Thromb. Hemost, vol. 21, pp.390-401.
- Andrew M., Vegh P., Johnston M.(1992) Maturaqtion of the Hemostatic System During ChildhoodBlood, vol.80(8), pp.1998-2005.
- Акалович С.Т., Нашкевич Н.Н., Кудин А.П., Астапов А.А., Войтенок Н.Н. Содер- жание растворимого рецептора TNF –p55, альфа-дефензинов и изоформ интерлейкина-8, IL-877 и IL-872 в крови детей // Мед. иммунол. 2005. Т. 7. № 5–6. С. 575–578.
- Berger M., Signorino E., Muraro M., Quarello P., Biasin E., Nesi F., Vassallo E., Fa gioli F. Monitoring of TNFR1, IL-2Ra, HGF, CCL8, IL-8 and IL-12p70 following HSCT and their role as GVHD biomarkers in paediatric patients // Bone Mar - row Transplant. 2013. Vol. 48. № 9. P. 1230–1236.
- Choi S.W., Kitko C.L., Braun T., Paczesny S., Yanik G., Mineishi S., Krijanovski O., Jones D., Whitfield J., Cooke K., Hutchinson R., Ferrara J.L., Levine J.E. Change in plasma tumor necrosis factor receptor 1 levels in the first week after myelo- ablative allogeneic transplantation correlates with severity and in cidence of GVHD and survival // Blood. 2008. Vol. 112. № 4. P.1539–1542.
Мезенхимальные стволовые клетки в терапии приобрретенной апластической анемии
- Bueno C., Roldan M., Anguita E., Romero-Moya D., Martin-antonio B. (2014)
- Young N.S., Kaufman D.W.(2008) The Epidemiology of Acquired Aplastic Anemia.Haematol. vol.93, pp.489-492.
- Heimpel H. (2000) Aplastic anemia before bone marrow transplantation and antilymphoc. globulin. Acta Haematol, vol. 103, pp. 11-15.
- John J.F.(1997) Society for Healthcare Epidemiology of America joint committee on the prevention of antimicrobial in hospitals.Clin Infect Dis, vol.25, pp. 584-599.
- Preoperative antibiotic prophylaxis.N Engi J Med, vol.236, pp.337-339. Baez-Martinez R., Rangel-Frausto M., Ponce de Leon S. (2000).
- Steliarova-Foucher E., Colombet M., Ries L.A.G., Hesseling P., Moremo F., Shin H.Y., Stiller C.A.(eds.) (2017) International Incidence of Childhood Cancer, Volume III (electronic version). Lyon, France: International Agency for Research on Cancer. (2006) National Vital Statistics Reports, vol. 54, no 13, April 19.
- Parkin D.M., MacLennan R., Muir C.S., Skeet R.G. (ed.)(1991). Cancer registration: principles and methods. Lyon: IARC scientific publication., 95, pp. 126-58.
Исследование влияние различных факторов на параметры качества образвцов пуповинной крови
- Gluckman E., Broxmeyer H.A., Auerbach A.D., Friedman H.S., Douglas G.W., Devergie A., Esperou H., Thierry D., Socie G., Lehn P.(1989) Hematopoietic reconstitution in a patient with Franconi's anemia by means of umbilical cord blood from an HLA-identical sibling.N.Engl.J.Med., vol.321, no 17, pp. 1174-1178.
- Kurtzberg J., Graham M., Casey J., Olson J., Stevens C.E., Rubinstein P.(1994) The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation.Blood Cell, vol.20, no 2-3, pp 275-283. 3. Reboredo N.M., Diaz A., Castro A., Villaescusa R.G. (2000) Collection, processing and cryopreservation of umbilical cord blood for unrelated trensplantation. Bone Marrow Transplant., vol.26, pp. 1263-1270.
- Scheinberg Ph., Wu C.O., Nunez O., Scheinberg Pr., Boss C., Sloand E.M., Young N.S.
- Saracco P., Quarello P., lori A.P., Zecca M., Longoni D., Svahn J.(2008)
- Novitzky N., Jacobs P.(1999)Eur.J.Hematol, no 63,pp. 141-148.
- Vora A., Goulden N., Wade R., Mitchell C.(2013) Tretment reduction for children and young aduits with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial. Lancet Oncol., vol. 14, no 3, pp. 199-209.
- Tallen G., Ratei R., Mann G., Kaspers G. (2010) Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90.J.Clin.Oncol., vol.28, no 14, pp.2339-2347.
- Raetz E.A., Michael J., Borowitz, Meenakshi, Devidas (2008) Reinduction platform for children with first marrow relapse of acute lymphoblastic leukemia: a Children's Oncology Group Study.American Society of Clinical Oncology,vol.26, no 24, p. 3971.
- Aleinikova O., Potapnev M., Syckevich O., Petrovich S., Ismail-zade R., Strongin Y. (2000) Dostijenia detskoy onkologii i hematologii v respublike Belaru's [Achievements for Rediatric Oncology and Hematology in the REpublic of Belarus].Aktualnye voprosy detskoy onkologii i hematologii:Materialy VIII mejdunarodnogo simpoziuma. Minsk, pp. 2-8.
- Sukonko O., Antonenkova N. (2011) Organizazionno-metodicheskaia pomoshh', okazyvaemaya gosudarstvennym uchrezdeniem RNPC OMR im. N.N. Aleksandrova organizaciyam zdravoohranenia v REspublike Belarus [Organizational and methodological assistance provided by a public institution RSPC OMR named Cente of MPAs them N.N. Alexandrova health organizations in the Republic of Belarus].Onkologicheskij zhurnal, vol. 20, pp. 42-45.
- Demidchik Yu., Oisarenko A., Fridman M., Baragina Z., Man'kovskaya S., Papok V. (2008) Neoperiruemyj rak shhitovidnoj zhelezy: e'ffektivnost' diagnostiki i vyzhivaemost' [Thyroid cancer: diagnostic perfomance and survival]. Oncologicheskij zhurnal, vol. 8, pp. 9-21.
Вопросы гематологии/онкологии и иммунопатологии В педиатрии
Новичкова Галина Анатольевна
Научно-практический журнал
- Nathan D., Oski F. Hematology of Infan- cy and Childhood, 3th ed. Philadelphia, W.B. Saunders, 1987; Vol. 1; 847 p.
- Cazzola M., Borgna-Pignatti C., Loca- telli F., Ponchio L., Beguin Y., De Stefano P. A moderate transfusion regimen may reduce iron loading in beta?thalassemia major without producing excessive ex- pansion of erythropoiesis. Transfusion 1997; 37 (2): 135–40.
- Cappellini M.D., Cohen A., Eleftheriou A., Piga A., Porter J., Taher A. Guidelines for the Management of Transfusion De- pendent Thalassaemia, 2nd Edition TIF, 2007, 203 p.
Антиангиогенная терапия локализованных форм саркомы Юинга у пациентов детского возраста
Киселёв Л.П.
Республиканский научно-практичнский центр детской онкологии, гематологии и иммунологии
- Aleinikova O., Potapnev M., Syckevich O., Petrovich S., Ismail-zade R., Strongin Y. (2000) Dostijenia detskoy onkologii i hematologii v respublike Belaru's [Achievements for Rediatric Oncology and Hematology in the REpublic of Belarus].Aktualnye voprosy detskoy onkologii i hematologii:Materialy VIII mejdunarodnogo simpoziuma. Minsk, pp. 3-8.
- Sukonko O., Antonenkova N. (2011) Organizazionno-metodicheskaia pomoshh', okazyvaemaya gosudarstvennym uchrezdeniem RNPC OMR im. N.N. Aleksandrova organizaciyam zdravoohranenia v REspublike Belarus [Organizational and methodological assistance provided by a public institution RSPC OMR named Cente of MPAs them N.N. Alexandrova health organizations in the Republic of Belarus].Onkologicheskij zhurnal, vol. 20, pp. 42-45.
- Demidchik Yu., Oisarenko A., Fridman M., Baragina Z., Man'kovskaya S., Papok V. (2008) Neoperiruemyj rak shhitovidnoj zhelezy: e'ffektivnost' diagnostiki i vyzhivaemost' [Thyroid cancer: diagnostic perfomance and survival]. Oncologicheskij zhurnal, vol. 8, pp. 9-21.
Результаты терапии опухолей семейства саркомы Юинга у детей Республики Беларусь
Киселёв Л.П.
Республиканский научно-практичнский центр детской онкологии, гематологии и иммунологии
- Aleinikova O.,Potapnev M., Syckevich O., Petrovich S., Ismail-zade R., Strongin Y.(2000) Dostijenia detskoy onkologii i hematologii v respublike Belarus's [Achievements for Pediatric Oncology and Hematology in the Republic of Belarus].Aktualnye voprosy detskoy onkologii i hematologii:Materialy VIII mejdunarodnogo simpoziuma. Minsk, pp. 3-8.
- Kisialeu L., Savitskaya T, Lipai N., Aleinikova O. TFPI2, VEGFA165 i VEGFA189 kak nezavisimye factory prognoza lokalizovannych form sarkomy luinga. Onkologicheskij zhurnal, vol. 10,pp. 93-100.
- Demidchik Yu., Pisarenko A., Fridman M, Baragina Z., Man'kovskaya S., Papok V. (2008) Neoperiruemyj rak shhitovidnoj zhelezy: e'ffektivnost' diagnostiki I vyzhivaemost' [Thyroid cancer: diagnostic perfomance and survival].Onkologicheskij zhurnal, vol. 8, pp. 9-21.
Маркеры ангиогенеза и антиангиогенная терапия у пациентов с локализованными формами саркомы Юинга
- Aleinikova O.,Potapnev M., Syckevich O., Petrovich S., Ismail-zade R., Strongin Y.(2000) Dostijenia detskoy onkologii i hematologii v respublike Belarus's [Achievements for Pediatric Oncology and Hematology in the Republic of Belarus].Aktualnye voprosy detskoy onkologii i hematologii:Materialy VIII mejdunarodnogo simpoziuma. Minsk, pp. 3-8.
- Sukonko O., Antonenkova Nat.(2011) Organizazionno-metodicheskaia pomoshh; okazyvaemaya gosudarstvennym uchrezdeniem RNPC OMP im, N.N. Aleksandrova organizaciyam zdravoohranenia v Respublic of Belarus'[Organizational and methodological assistance provided by a public institution RSPC OMR named Center of MPAs them. N.N. Alexandrova health organizations in the Republic of Belarus].Onkologicheskij zhurnal, vol, 20, pp.42-45
- Demidchik Yu., Pisarenko A., Fridman M, Baragina Z., Man'kovskaya S., Papok V. (2008) Neoperiruemyj rak shhitovidnoj zhelezy: e'ffektivnost' diagnostiki I vyzhivaemost' [Thyroid cancer: diagnostic perfomance and survival].Onkologicheskij zhurnal, vol. 8, pp. 9-21.
- Петрович С.В., Алейникова О.В., Лапотентова Е.С., и др. Особенности заболеваемости злокачест- венными новообразованиями детей первого года жизни в Республике Беларусь // Медико- биологические аспекты аварии на Чернобыльской АЭС. — 2004. — №1 — С. 3–11. [Petrovich SV, Aleinikova OV, Lapotentova ES, et al. Osobennosti zabolevaemosti zlokachestvennymi novoobra- zovaniyami detei pervogo goda zhizni v Respublike Belarus’. Mediko-biologicheskie aspekty avarii na Chernobyl’skoi AES. 2004;(1):3–11. (In Russ).]
- Мень Т.Х., Поляков В.Г., Алиев М.Д. Эпидемиология злокачественных новообразований у детей в России // Онкопедиатрия. — 2014. — Т.1. — №1 — С. 7–12. [Men TC, Polyakov VG, Aliev MD. Epidemiology of childhood cancer in Russia. Oncopediatrics. 2014;1(1):7–12. (In Russ).]
- Bacci G, Forni C, Longhi A, et al. Long-term outcome for patients with non-metastatic Ewing’s sarcoma treated with adjuvant and neoadjuvant chemothera- pies. 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer. 2004;40(1):73–83. doi: 10.1016/j.ejca.2003.08.022.
- Петрович С.В., Алейникова О.В., Лапотентова Е.С., и др. Особенности заболеваемости злокачест- венными новообразованиями детей первого года жизни в Республике Беларусь // Медико- биологические аспекты аварии на Чернобыльской АЭС. — 2004. — №1 — С. 3–11. [Petrovich SV, Aleinikova OV, Lapotentova ES, et al. Osobennosti zabolevaemosti zlokachestvennymi novoobra- zovaniyami detei pervogo goda zhizni v Respublike Belarus’. Mediko-biologicheskie aspekty avarii na Chernobyl’skoi AES. 2004;(1):3–11. (In Russ).]
- Мень Т.Х., Поляков В.Г., Алиев М.Д. Эпидемиология злокачественных новообразований у детей в России // Онкопедиатрия. — 2014. — Т.1. — №1 — С. 7–12. [Men TC, Polyakov VG, Aliev MD. Epidemiology of childhood cancer in Russia. Oncopediatrics. 2014;1(1):7–12. (In Russ).]
- Bacci G, Forni C, Longhi A, et al. Long-term outcome for patients with non-metastatic Ewing’s sarcoma treated with adjuvant and neoadjuvant chemothera- pies. 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer. 2004;40(1):73–83. doi: 10.1016/j.ejca.2003.08.022.
- Петрович С.В., Алейникова О.В., Лапотентова Е.С., и др. Особенности заболеваемости злокачест- венными новообразованиями детей первого года жизни в Республике Беларусь // Медико- биологические аспекты аварии на Чернобыльской АЭС. — 2004. — №1 — С. 3–11. [Petrovich SV, Aleinikova OV, Lapotentova ES, et al. Osobennosti zabolevaemosti zlokachestvennymi novoobra- zovaniyami detei pervogo goda zhizni v Respublike Belarus’. Mediko-biologicheskie aspekty avarii na Chernobyl’skoi AES. 2004;(1):3–11. (In Russ).]
- Мень Т.Х., Поляков В.Г., Алиев М.Д. Эпидемиология злокачественных новообразований у детей в России // Онкопедиатрия. — 2014. — Т.1. — №1 — С. 7–12. [Men TC, Polyakov VG, Aliev MD. Epidemiology of childhood cancer in Russia. Oncopediatrics. 2014;1(1):7–12. (In Russ).]
- Bacci G, Forni C, Longhi A, et al. Long-term outcome for patients with non-metastatic Ewing’s sarcoma treated with adjuvant and neoadjuvant chemothera- pies. 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer. 2004;40(1):73–83. doi: 10.1016/j.ejca.2003.08.022.
- Sei Y.,(2015) Epidemiological Survey of Dermatomycoses in Japan.Med Mycol J.,vol. 56, no 4, pp. J129-35. doi:10.3314/J129-35
- Agusti C., Torres A. (2009) Pulmonary Infection in the Immunocompromised Patient: Strategies for Management.Jhon Wiley&Sons. p.456.
- Harrison N., Mitterbauer M. (2015) Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study.BMC Infect Dis., vol.15 p.584.
Международный научно-практический журнал
Евразийский онкологисеский журнал
2017, том 5, №3
Главный редактор - Давыдов М.И. (Россия, Москва)
- Servais S., Beguin Y., Baron F. (2013) Emerging drugs for prevention of graft failure ather allogeneic hematopoietic stem cell transplantation. Expert Opin. Emerg. Drugs, vol.18, no2, pp.173–192. doi:10.1517/14728214.2013.798642.
- Tracey J., Zhang M.J., Thiel E., Sobocinski K.A., Eapen M. (2013) Transplantation Conditioning Regimens and Outcomes ather Allogeneic Hematopoietic Cell Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia. Biol. Blood Marrow Transplant., vol. 19, no 2, pp.255–259. doi:10.1016/j.bbmt.2012.09.019
- Majhail N.S., Brazauskas R., Hassebroek A., Bredeson C.N., Hahn T., Hale G.A., Horowitz M.M., Lazarus H.M., Maziarz R.T., Wood W.A., Parsons S.K., Joe S., Rizzo J.D., Lee S.J., Hayes-Lattin B.M. (2012) Outcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared with children and older adults with acute myeloid leukemia. Biol. Blood Marrow Transplant., vol.18, no 6, pp. 861–873. doi:10.1016/j.bbmt.2011.10.031.
Достижения в терапии острого лимфобластного лейкоза у молодых взрослых Республики Беларусь
- Vora A., Goulden N. (2014) Augmented post-remission therapy for a minimal residual diseasedefined high-risk subgroup of children young people with clinical standard-risk and intermediate-risk acute lymphoblastic leulaemia (UKALL 2003): a randomised controlled trial. Lancet Oncology (electronic journal), vol. 15, no 8, pp. 809-18. dol: 10.1016/S1470-2045(14)70243-8
- Henze G., v Stackelberg A., Eckert C. (2013) ALL-REZ BFM - the consecutive trial for children with relapsed acute lymphoblastic leukemia. Klinische Padiatrie(electronic journal), vol. 1, pp. S73-78.dol: 10.1055/s-0033-1337967
- von Stackelberg A., Volzke E., Kuhl J. (2011) Outcome children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: a retrospective analysis of the ALL-REZ BFM Study Group.European Journal of Cancer (electronic journal), vol. 47, no 1, pp. 90-7. doi: 10.1016/j.ejca.2010.09.020
Трансплантации гемопоэтических стволовых клеток у детелей и молодых взрослых в Республике Беларусь
- Schrauder A., von Stackelberg A., Schrappe M. (2008) Allogeneic hemtopoietic SCT in children with ALL: Current concepts of ongoing prospective SCT trial.Bone Marrow Transplant., vol. 41, suppl. 2, pp. 71-74.
- Bader P., Kreyenberg H., Henze G. (2009) Prognostic value of minimal residual disease quantification before allogeneic stern-cell transplantation in relapsed childhood acute lymphoblastic leukemia: The ALL-REZ BFM Study Group.J.Clin. Oncol., vol. 27, pp. 377-384.
- MсCune S., Jacobson P., Wiseman A., Militano O.(2015) Optimizing drug therapy in pediatric SCT: Focus on pharmacokinetics.Bone Marrow Transplant., vol. 50, pp. 165-172.
- Lanskovski F (2005.) Detskaja gematologija i oncologija [Children's Hematology and Oncology]. Moskva, pp. 484-485.(in Russian).
- Durnova L. (2004) Klinicheskie lekcii po detskoi onkologii [Clinical lectures on pediatric Oncology]. Moskva, pp. 145-157.(in Russian).
- Cheung. N, Kuahner B., Quaglia M. (1997) Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers. Eur.J Cancer, vol. 33, pp.117-120
Достижения в терапии острого лимфобластного лейкоза у молодых взрослых Республики Беларусь
- Vora A., Goulden N.(2014) Augmented post-remission therapy for a minimal residual diseasedefined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial. Lancet Oncology (electronic journal), vol. 15, no 8, pp. 809-18. doi: 10.1016/S1470-2045(14)70243-8.
- Henze G., v Stachelberg A., Eckert C.(2013) ALL-REZ BFM--the consecutive rieals for children with relapsed acute lymphoblastic leulemia.Klinische Padiatrie (electronic journal), vol. 1,pp. S73-78. doi: 10.1055/s-0033-1337967
- von Stackelberg A., Volzke E., Kuhl J.(2011) Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: a retrospective analysis of the ALL-REZ BFM Study Group. European Journal of Cancer(electronic journal), vol. 47, no 1, pp. 90-7. doi: 10.1016/j.ejca.2010.09.020
Противораковая ДНК-вакцинация: принцип и возможности метода
- Попов Ю.А., Микшис Н.И. Генетические (ДНК) вакцины // Проблемы особо опасных инфекций, 2010. T. 105. C. 20-24. [Popov Yu.A., Mikshis N.I. Genetic (DNA) vaccines. Problemy osobo opasnykh infektsiy = Plague Problems, 2010 ,Vol. 105, pp. 20-24. (In Russ.)]
- Южакова Д.В., Ширманова М.В., Сергеева Т.Ф., Загайнова Е.В., Лукъянов К.А. Иммунотерапия злокачественных новообразований // Современные технологии в медицине, 2016. Т. 8, № 1. С. 173-182. [Yuzhakova D.V., Shirmanova М.V., Sergeeva Т.F., Zagaynova E.V., Lukyanov К.А. Immunotherapy of Cancer. Sovremennye tekhnologii v meditsine = Modern Technologies in Medicine, 2016, Vol. 8, no. 1, pp. 173-182. (In Russ.)]
- Ardolino M., Hsu J., Raulet D.H. Cytokine treatment in cancer immunotherapy. Oncotarget., 2015, Vol. 6, no. 23, pp. 19346-19347.
- Reiter A. (2000) Intensive ALL-type therapy without local radiotherapy provides a 90% event-free sur- vival for children with T-cell lymphoblastic lymphoma: A BFM group report. Blood, vol. 95, pp. 416–421.
- Burkhardt B., Woessmann W., Zimmermann M. (2006) Impact of cranial radiotherapy on central ner- vous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma. J. Clin. Oncol., vol. 24, pp. 491–499.
- Patte C., Auperin A., Gerrard M. (2007) Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood, vol.109, pp. 2773–2780.
Лечение рецидивов анапластической крупноклеточной лимфомы у детей и подростков
- Reiter A., Schrappe M., Parwaresch R. (1995) Non-hodgkin's lymphomas of childhood and adoiescence: Results of a treatment stratified for biologic subtypes and stage - A report of the Berlin-Frankfurt-Munster Group.J Clin Oncol, vol. 13, pp. 359-372.
- Liang X., Meech SJ., Odom L.F.,(2004) Assessment of t(2;5)(p23;q35) transiocation and variants in pediatric ALK+anaplastic large cell lymphoma.Am J Clin Pathol, vol. 121, pp.496-506.
- Brugieres L., Le Deley M.C., Pacquement H.(1998) CD30(+) anaplastic large cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology.Blood, vol, 92, pp. 3591-3598.
2018
- M. Cortes, E. Wong, J. Koipally, K. Georgopoulos, Control of lymphocyte develop- ment by the Ikaros gene family, Curr. Opin. Immunol. 11 (1999) 167–171 http:// www.ncbi.nlm.nih.gov/pubmed/10322160 (accessed November 17, 2014).
- B.S. Cobb, S.T. Smale, Ikaros-family proteins: in search of molecular functions during lymphocyte development, Curr. Top. Microbiol. Immunol. 290 (2005) 29–47 http://www.ncbi.nlm.nih.gov/pubmed/16480038.
- K. Georgopoulos, M. Bigby, J.H. Wang, A. Molnar, P. Wu, S. Winandy, et al., The Ikaros gene is required for the development of all lymphoid lineages, Cell 79 (1994) 143–156 http://www.ncbi.nlm.nih.gov/pubmed/7923373.
Медицина. Научно-практический рецензируемый журнал
- Abdominal aortic aneurysm: A comprehensive review / S. Aggarwal [et al.] // Exp Clin Cardiol. – 2011:16(1). – P. 11-15.
- Кубанский регистр острых расслоений аорты типа А (регистр КУБРАДА) / К. О Барбухатти [и др.] // Кардиология и сердечно-сосудистая хирургия. – 2014. – №6. – С. 38-41.
- Stenting of thoracic aortic aneurysms in for De Bakey type 111 aortic dissection / S. A. Abugov [et al.] // Journal named after №.1. Pirogov. – 2013:2. – P. 67-72
- Алейникова О.В., Потапнев М.П., Сыцкевич О.Н. и др. Достижения детской онкологии и гематологии в Республике Беларусь. Актуальные вопросы детской онкологии и гематологии: Материалы VIII международного симпозиума. Минск, 2000. С. 3–8. [Aleynikova O.V., Potapnev M.P., Syckevich O.N. et al. Achieve- ments of children’s oncology and hematology in the Republic of Belarus. Actual questions of children’s oncology and hematology: Proceed- ings of the VIII International Symposium. Minsk, 2000. Pp. 3–8. (In Russ.)].
- Румянцев А.Г., Варфоломеева С.Р., Грачев Н.С., Карачунский А.И., Новичкова Г.А. Принципы и инструменты доказательной медицины в детской гематологии/онкологии. Доктор.ру 2015;10(111):6–13. [Rumyantsev A.G., Var- folomeeva S.R., Grachev N.S., Karachunskiy A.I., Novichkova G.A. Princi- ples and tools of evidence-based medicine in pediatric hematology/oncology. Doctor.ru 2015;10(111):6–13. (In Russ.)].
- Ries L.A., Smith M.A., Gurney J.G. et al. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. Bethesda, MD, 1999.
- Boyle J.M., Buckley R.H.(2007) Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol, vol.27, no 5, pp. 497-502.
- Reust C.E. (2013) Evaluation of Primary Immunodeficiency Disease in Children. Am Fam Physician, vol. 87, no 11, pp. 773-778.
- Picard C., Al-Herz W., Bousfiha A., Casanova J.L., Chatila T., Conley M.E., Cunningham-Rundles C., Etzioni A., Holland S.M., Klein C., Nonoyama S., Ochs H.D., Oksenhendler E., Puck J.M., Sullivan K.E., Tang M.L., Franco J.L., Gaspar H.B.(2015) Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol, vol.35, no 8, pp. 696-726.
Международный научно-практический журнал Евразийский Онкологический Журнал
- Zelm M.C., Burg M., Langerak A.W. (2011) PID comes full circles: applications of V(D)J recombination excision circles in research, diagnostics and newborn screening of primary immunode?ciency disorders. Frontiers in immunology, vol. 2, no 12, pp. 1–7.
- Puck J.M. (2012) Laboratory technology for population-based screening for severe combined immunode?ciency in neonates: the winner is T-cell receptor excision circles. J Allergy Clin Immunol, no 129, pp. 607–616.
- Verbsky J., Thakar M., Routes J. (2012) The Wisconsin approach to newborn screening for severe combined immunode?ciency. J Allergy Clin Immunol, vol. 129, no 3, pp. 622–627.
Международный научно-практический журнал Евразийский Онкологический Журнал
- Zelm M.C., Burg M., Langerak A.W. (2011) PID comes full circles: applications of V(D)J recombination excision circles in research, diagnostics and newborn screening of primary immunode?ciency disorders. Frontiers in immunology, vol. 2, no 12, pp. 1–7.
- Puck J.M. (2012) Laboratory technology for population-based screening for severe combined immunode?ciency in neonates: the winner is T-cell receptor excision circles. J Allergy Clin Immunol, no 129, pp. 607–616.
- Verbsky J., Thakar M., Routes J. (2012) The Wisconsin approach to newborn screening for severe combined immunode?ciency. J Allergy Clin Immunol, vol. 129, no 3, pp. 622–627.
2019
-
УЧРЕЖДЕНИЕ - РАЗРАБОТЧИК: государственное учреждение «Республиканский научно-практический центр детской онкологии, гематологии и иммунологии»
АВТОРЫ: Лис А.П., Кондаурова С.Л., Панасюк Ю.В., Литуновская Л.Г., Кульбицкая Т.Т., Секацкая Т.Е., Миренкова Ю.В., д.м.н., проф., член-корреспондент НАН Беларуси Алейникова О.В., д.м.н., проф. Конопля Н.Е.
-
УЧРЕЖДЕНИЕ - РАЗРАБОТЧИК: государственное научное учреждение «Институт биоорганической химии НАН Беларуси», государственное учреждение «Республиканский научно-практический центр детской онкологии, гематологии и иммунологии»
АВТОРЫ: д.х.н., профессор, чл.-корр. НАН Беларуси Усанов С.А., к.х.н. Гилеп А.А., к.б.н. Белевцев М.В., Шкель Т.В., Секацкая Т.Е., Кульбицкая Т.Т., Кондаурова С.Л., Райко Т.В., Скоповец Е.Я.
МЕТОД ИДЕНТИФИКАЦИИ ДРОЖЖЕВЫХ И МИЦЕАЛЬНЫХ ПАТОГЕННЫХ ГРИБОВ. Инструкция по применению